The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis Publisher Pubmed



Roudsari PP¹ ; Alavimoghadam S² ; Rezaeitavirani M³ ; Goodarzi P⁴ ; Tayanloobeik A¹ ; Sayahpour FA⁵ ; Larijani B⁶ ; Arjmand B^{1, 2} Show Affiliations
Source: Advances in Experimental Medicine and Biology Published:2021

Abstract

Rheumatoid arthritis as a common autoimmune inflammatory disorder with unknown etiology can affect 0.5–1% of adults in developed countries. It involves more than just the patient’s joints and can be accompanied by several comorbidities and affect cardiovascular, pulmonary, and some other systems of the human body. Although cytokine-mediated pathways are mentioned to have a central role in RA pathogenesis, adaptive and innate immune systems and intracellular signaling pathways all have important roles in this process. Non-steroidal anti-inflammatory drugs, glucocorticoids, conventional disease-modifying anti-rheumatic drugs, and biological agents are some mentioned medications used for RA. They are accompanied by some adverse effects and treatment failures which elucidates the needing for novel and more powerful therapeutic approaches. Stem cell-based therapies and their beneficial effects on therapeutic processes of different diseases have been founded so far. They can be an alternative and promising therapeutic approach for RA, too; due to their effects on immune responses of the disease. This review, besides some explanations about RA characteristics, addresses the outcome of the stem cell-based therapies including mesenchymal stem cell transplantation and hematopoietic stem cell transplantation for RA and explains their effects on the disease improvement. © 2020, Springer Nature Switzerland AG.